Evidence map›Paper›PMID 27893301›Full record

ArticleBioengineered2017

Optimizing the expression of a Heterologous chitinase: A study of different promoters.

Abigail F da Silva, Belén García-Fraga, Jacobo López-Seijas, Carmen Sieiro

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Bacterial chitinases: genetics, engineering and applications.World journal of microbiology & biotechnology · 2022
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abigail F da Silvaa Department of Functional Biology and Health Sciences , Microbiology Area, University of Vigo, Lagoas - Marcosende , Vigo , Spain.
Belén García-Fragaa Department of Functional Biology and Health Sciences , Microbiology Area, University of Vigo, Lagoas - Marcosende , Vigo , Spain.
Jacobo López-Seijasa Department of Functional Biology and Health Sciences , Microbiology Area, University of Vigo, Lagoas - Marcosende , Vigo , Spain.ORCID http://orcid.org/0000-0002-7440-5241
Carmen Sieiroa Department of Functional Biology and Health Sciences , Microbiology Area, University of Vigo, Lagoas - Marcosende , Vigo , Spain.
Universidade de Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many relevant applications have been demonstrated for chitinolytic enzymes. However, their successful exploitation depends upon the availability of strains and expression conditions that allow the production of active forms and large quantities of these enzymes. Escherichia coli has been commonly used to express and overproduce different proteins, among them chitinases. Improving the functional gene expression of chitinases is key to exploiting their potential. In a recent study, we described the effect of various parameters on the functional expression of 2 chitinases from different families, demonstrating that the effect of each of these parameters on the activity of both chitinases was specific to each enzyme. In this study, the expression of a Lactococcus lactis chitinase encoded by a new allele, ChiA1-2, was optimized. The results showed that not only the expression parameters seemed to influence protein production, solubility and activity but also the plasmid used for the expression. Herein, we describe the effect of 2 different promoters, tac and T7, on the expression of the active form of the chitinolytic enzyme.

Indexed as

ChitinasesEscherichia coliGenetic EnhancementLactococcus lactisMetabolic EngineeringPromoter Regions, GeneticRecombinant ProteinsUp-RegulationChitinasesRecombinant Proteinsheterologous expressionpromotersrecombinant chitinase

Identifiers

PMID27893301
PMCPMC5553332
OpenAlexW2559182362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.